ArticleAMB Express2025
An effective method to enhance transient gene expression by transfecting high-density CHO cells.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Optimization of PEI-mediated transient transfection for antibody production in Expi293F cells by iron ion supplementation.Biochemistry and biophysics reports · 2026Article
- Correction: An effective method to enhance transient gene expression by transfecting high-density CHO cells.AMB Express · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
Chinese hamster ovary (CHO) cells are the predominant host for recombinant protein production. While transient gene expression (TGE) systems provide a faster, more cost-effective alternative to stable gene expression (SGE), their application is often hampered by low protein yields. Here, we optimized TGE systems based on high-density suspension transfection using 40 kDa polyethylenimine (PEI) by engineering vector regulatory elements (Kozak, polyA, introns, leader) and optimizing transfection conditions. Vector optimization led to a substantial enhancement in recombinant protein, with EGFP and SEAP levels increased by 5.33-fold and 4.13-fold, respectively (p < 0.05). By applying the optimized vector in combination with identified optimal conditions, a DNA concentration of 4 µg/mL, a DNA: PEI mass ratio of 1:5, and a repeated transfection strategy, we achieved a transfection efficiency of 76.34% while maintaining cell viability above 85%. Moreover, the combined optimization of vectors and transfection conditions robustly enhance the production of therapeutically relevant proteins, increased the expression of recombinant type III human collagen and human serum albumin by 4.86-fold and 5.50-fold, respectively (p < 0.05). In summary, high-density suspension transfection markedly boosts transient recombinant protein expression in CHO cells by improving transfection efficiency, expanding the population of recombinant cells, and maintaining high cell viability. This approach presents a promising and effective strategy for high yield transient transgene expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.